Loading...
XSWX
MEDX
Market cap547mUSD
Dec 05, Last price  
10.78CHF
1D
1.89%
1Q
2.08%
IPO
-75.61%
Name

medmix AG

Chart & Performance

D1W1MN
XSWX:MEDX chart
P/E
P/S
0.91
EPS
Div Yield, %
4.64%
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
2.84%
Revenues
484m
-0.55%
454,000,000420,700,000351,300,000457,300,000477,100,000486,600,000483,900,000
Net income
-7m
L
52,200,00025,200,0009,600,00044,000,00011,600,000300,000-7,400,000
CFO
87m
+54.37%
94,200,00089,100,00050,600,00087,300,00047,600,00056,100,00086,600,000
Dividend
Apr 26, 20240.5 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.
IPO date
Sep 30, 2021
Employees
2,245
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT